LOW AND INTERMEDIATE RISK PROSTATE CANCER
Clinical trials for LOW AND INTERMEDIATE RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW AND INTERMEDIATE RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for LOW AND INTERMEDIATE RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Laser zaps prostate tumors without major surgery
Disease control Recruiting nowThis study tests a laser treatment guided by MRI to destroy early-stage prostate cancer in men aged 40-80 with low to intermediate risk. The goal is to control the cancer and avoid more aggressive treatments like surgery or radiation. Researchers will check results with follow-up…
Matched conditions: LOW AND INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Laser zaps prostate tumors without major surgery
Disease control Recruiting nowThis study tests a new, less invasive way to treat intermediate-risk prostate cancer using a laser guided by micro-ultrasound. The goal is to see if the procedure is safe and can delay or avoid the need for more aggressive treatments like surgery or radiation. Seven men aged 40-8…
Matched conditions: LOW AND INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC